HLS THERAPEUTICS INC (HLS.TO) Financials
HLS.TO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 267.4 million | 147.0 million |
2023-12-31 | 277.3 million | 147.7 million |
2023-09-30 | 292.5 million | 154.2 million |
2023-06-30 | 300.3 million | 152.7 million |
HLS.TO Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | 1.0 million | 346177 |
2023-12-31 | 4.9 million | -797136 |
2023-09-30 | 7.2 million | -25821 |
2023-06-30 | 3.4 million | 181361 |
HLS.TO Net Income
No data available :(
HLS.TO Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | - | - | 995259 |
2023-12-31 | - | - | 1.2 million |
2023-09-30 | 29.6 million | 116.2 million | 1.3 million |
2023-06-30 | 27.7 million | 108.0 million | 1.3 million |
HLS.TO Shares Outstanding
HLS.TO Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 2704 | - | 9.4 million | - |
2023-12-31 | 18568 | - | 8.0 million | - |
2023-09-30 | 237833 | - | 12.3 million | - |
2023-06-30 | 35742 | - | 12.3 million | - |
HLS.TO Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 16.9 million | 2.4 million |
2023-12-31 | 21.0 million | 3.4 million |
2023-09-30 | 21.8 million | 2.5 million |
2023-06-30 | 21.7 million | 2.4 million |
HLS.TO
Price: CA$3.88
Forward Dividend Yield: 5.15%
Payout Ratio: -4.31%
Dividend Per Share: 0.20 CAD
Earnings Per Share: -1.17 CAD
P/E Ratio: -3.52
Exchange: TOR
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 125.3 million
Average Dividend Frequency: 3
Years Paying Dividends: 6